January 16, 2025
12 min watch
Save
VIDEO: ‘Still in the dark ages’ in how to best monitor geographic atrophy
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
CHICAGO — In this video, Clement K. Chan, MD, FACS, discusses highlights from the AAO meeting, including presentations on pegcetacoplan and avacincaptad pegol for the treatment of geographic atrophy.
In addition, Chan, a retina specialist at Desert Retina Consultants, recaps a panel discussion during which experts shared their opinions on the use of these therapies for the treatment of GA.
References:
- Brown D. Pegcetacoplan for geographic atrophy in AMD. Presented at: American Academy of Ophthalmology meeting; Oct. 18-21, 2024; Chicago.
- Jaffe G. Avacincaptad for geographic atrophy in AMD. Presented at: American Academy of Ophthalmology meeting; Oct. 18-21, 2024; Chicago.
Chan reports no relevant financial disclosures.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Chan reports no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.